Christina Vorvis
Director - Ventures Abbvie Ventures
Christina Vorvis, PhD is Director, East Coast Ventures at AbbVie, where she leads investments in early-stage companies developing transformative therapies and technologies for cancer, immunology, neuroscience, eye care, and aesthetics based in Cambridge, Massachusetts. Christina has over 10 years of experience in the Life Sciences, including benchside research, digital health startups, investment banking, and deal origination and deal execution at global institutions like Amgen, OrbiMed, and Back Bay Life Science Advisors. She earned her PhD in Cancer Biology from the University of California, Los Angeles where she studied the molecular mechanisms of tumor growth and progression in pancreatic cancer. Prior to joining AbbVie, Christina advised biotech and pharmaceutical companies on mergers and acquisitions, financings, and other strategic transactions. In her current role at AbbVie, Christina is passionate about using her expertise to help innovative companies develop and commercialize new therapies and technologies that improve the lives of patients around the world.
Seminars
The biopharmaceutical sector continues to seek new opportunities to leverage mRNA technology and thrives on strategic alliances, which allow for cross-functional sharing of knowledge, skills, and experience across different disciplines to truly advance mRNA drugs to patients faster. Hear first-hand how biopharma business development leaders and investors are taking their time to evaluate novel innovations and building new collaborations.
- Leveraging the past experiences of recent deals, collaborations and acquisitions in mRNA-LNP platforms to inform future risk and decision-making strategies
- Where do you see potential white spaces that mRNA can fill within this sector or indications more specifically?
- What data is required and how far does an asset have to progress towards future investment or acquisition success?
